Tag Archives: dasatinib

NICE deny Leukaemia Patients Life Saving Cancer Drugs

NICE (National Institute for Health and Clinical Excellence) have recently returned their provisional results on Nilotinib and Dasatinib as alternative therapy for Imatinib (Glivec / Gleevec) intolerant patients. Basically they are denying these patients a chance of life on what … Continue reading

Leave a Comment

Filed under chronic myeloid leukaemia, gleevec, glivec, imatinib, leukaemia, NICE

CML – NICE – epetition response – Dasatinib (DS) & Nilotinib (NL)

Just a quick post to show the reply to 10 Downing Street’s latest reply to the Dasatinib and Nilotinib petiton and challenge to acceptance as 2nd line therapy for resistant / intolerant Imatinib (aka Glivec, Gleevec). I am not going … Continue reading

Leave a Comment

Filed under chronic myeloid leukaemia, gleevec, glivec, imatinib, leukaemia, leukaemia research

Understanding CML, Glivec, PCR results and where I fit in.

I have many questions asked around what is Chronic Myeloid Leukaemia (CML), Glivec (aka. Gleevec, Imatinib, STI571) what are my results and how are they measured. Dr Brian J Druker whom was instrumental in the development of Glivec did a … Continue reading

7 Comments

Filed under chronic myeloid leukaemia, gleevec, glivec, imatinib, leukaemia, leukaemia & lymphoma research